91porn

戴文玲
副研究员硕士生导师

电话:邮箱:[email protected]

办公室地址:综合研发楼G334

研究领域:中药抗慢性疼痛的神经-免疫机制及药效物质基础研究

招生方向:中药药理

  • 个人简介
  • 教学与课程
  • 研究方向
  • 项目与成果
  • 奖励荣誉
  • 教材或专著
  • 课题组介绍
  • 戴文玲,91porn 副研究员。长期致力于中药及天然产物抗慢性疼痛的神经-免疫机制及药效物质基础研究。先后主持国家自然科学基金面上项目,国家自然科学基金青年基金项目,中国博士后科学基金特别资助项目,中国博士后科学基金面上资助项目及中央高校团队类项目与培育项目。以第一作者或通讯作者在Cell Metabolism, Gut Microbes, Experimental and Molecular MedicineJournal of Advanced ResearchPhytomedicine等权威期刊发表论文多篇,获授权发明专利1项。


  • 药用植物学

    药用植物学实验

    药用植物性野外实践


  • 基于神经-免疫互作与中枢敏化机制,开展中药及天然产物抗慢性疼痛的药效物质基础与作用机制研究。

  • 1.国家自然科学基金面上项目,82574729,基于肝脑同治探讨金铃子散抑制肝Th17/IL-17-迷走神经轴缓解原发性肝癌疼痛的作用机制,2026-202949万元,主持

    2.国家自然科学基金面上项目,82370804circPde5a介导线粒体-内质网通讯维持钙稳态改善胰岛β细胞功能的机制研究,2024-202749万元,参与

    (1) Rui Zhang&, Mingxiao Li&, Hui Tan, Jianyao Liu, Lu Wang, Wenling Dai*, Zhimin Fan*,and Jihua Liu*. A new gut pathogenic bacteria and its metabolites promote colorectalcancer development and act as non-invasive early diagnostic biomarkers.Gut Microbes. 2025;17(1):2555446.

    (2) Junjie Wang&, Xinyuan Sun&, Xiangfei Gong&, Wenling Dai&, Hao Hong, Li Jiang, Zhonglong Wang, Zhiyuan Tang, Xiaobo Wu, Peng Sun, Yongjie Zhang, Kun Hao, Fang Zhou, Ying Cui, Tianyu Tang, Xiao Zheng, Lanqun Mao, Guangji Wang, Haiping Hao*, Hao Xie*. Galnt2 neurons in the ventromedial hypothalamuscounterregulate hypoglycemia via a brain-liverneurocircuit. Cell Metab. 2025, 4;37(11):2264-2279.e10.

    (3)Chang-Heng Yao, Zi-Meng Zhang, Shen Zhang, Han Jiang, Rui Wang, Ji-Hua Liu*, Hao Xie*, Wen-Ling Dai*.Berbamine alleviates neuropathic pain via suppressing spinal TMEM34/SGK1/FOXO3 axis. Phytomedicine. 2025, 140:156619.

    (4) Yu-Jie Yang, Shen Zhang, Jin Yang, Chang-Heng Yao, Xue Li, Wen-Ling Dai*, Ji-Hua Liu*. The aqueous extract of Armadillidium vulgare Latreille alleviates neuropathic pain via inhibiting neuron-astrocyte crosstalk mediated by the IL-12-IFN-γ-IFNGR-CXCL10 pathway. Journal of Ethnopharmacology. 2025, 340:119173.

    (5) Wen-Ling Dai&, Yi-Ni Bao&, Ji-Fa Fan, Bin Ma, Shan-Shan Li, Wan-Li Zhao, Bo-Yang Yu*, Ji-Hua Liu*. Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain. Journal of Advanced Research. 2021, 28:139-148.